Wet Scans

SPACE MEDICINE

Wet Scans

illustration only

Rehovot - Apr 20, 2004
The "scanning electron microscope" (SEM) has been a basic research tool for fifty years, and for those fifty years, scientists have been looking for better ways to observe biological samples under its beam.

The problem is that the viewing chamber of the SEM must contain a vacuum (in which liquid water in tissues "boils" away). To overcome this difficulty, scientists have had to resort to all sorts of complicated procedures, including coating the specimens with an ultra-fine layer of gold, quick-freezing samples in special deep-freezes, or treating them with drying solvents.

Now, scientists at the Weizmann Institute of Science have found a way to view samples of biological materials in their natural, "wet" state. Their secret lies in the production of a very thin but tough polymer capsule to enclose the sample, allowing it to withstand the force of the vacuum.

Says Dr. Ory Zik, who worked on the capsule with Professor Elisha Moses of the Physics of Complex Systems Department: "The material for the capsule is a result of advances in the area of semiconductors. We came across it while researching ways to apply automation techniques used in the semiconductor industry to the life sciences' scanning electron microscopes."

The capsule's polymer is unique in that it is allows the electrons with which a SEM works to pass through unobstructed, giving scientists a clear view of what lies within, without the use of tricky, tissue-distorting procedures. Researchers hope the new method will advance the studies of biological materials, such as the lipids that make up fat, which are easily destroyed by the old sample preparation methods.

Since the discovery was made, Zik, in cooperation with Yeda, the business arm of the Weizmann Institute, has founded a company, called QuantomiX, based on this technology. The findings of the team were published in the March 9 Proceedings of the National Academy of Sciences, USA (PNAS).

SPACE MEDICINE

Antibodies Break The Cell Barrier

London - Apr 15, 2004
Superantibodies that can bind to targets within cells, rather than on their surface, could lead to a new range of treatments for diseases, a biotech company claims in a report by New Scientist this week.

Thanks for being here; We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain. With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords. Our news coverage takes time and effort to publish 365 days a year. If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor $5 Billed Once credit card or paypal		SpaceDaily Monthly Supporter $5 Billed Monthly paypal only

The content herein, unless otherwise known to be public domain, are Copyright 1995-2016 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement All images and articles appearing on Space Media Network have been edited or digitally altered in some way. Any requests to remove copyright material will be acted upon in a timely and appropriate manner. Any attempt to extort money from Space Media Network will be ignored and reported to Australian Law Enforcement Agencies as a potential case of financial fraud involving the use of a telephonic carriage device or postal service.